Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial

Viridian Therapeutics (VRDN) Insider Trading & Ownership

$23.61
+0.86 (+3.78%)
(As of 10/1/2024 ET)

Viridian Therapeutics (NASDAQ:VRDN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.65%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$40.62 M
Number Of
Insiders Selling
(Last 12 Months)
0

VRDN Insider Buying and Selling by Quarter

Viridian Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/27/2024Stephen F MahoneyCEOBuy21,400$23.33$499,262.00  
9/27/2024Thomas W BeethamCOOBuy5,000$23.41$117,050.00  
9/13/2024Fairmount Funds Management LlcDirectorBuy1,600,000$18.75$30,000,000.00  
1/22/2024Fairmount Funds Management LlcDirectorBuy476,190$21.00$9,999,990.00  
(Data available from 1/1/2013 forward)

VRDN Insider Trading Activity - Frequently Asked Questions

The list of insiders at Viridian Therapeutics includes Barrett Katz, Fairmount Funds Management Llc, Jonathan Violin, Lara Meisner, Scott Dunseth Myers, Stephen F Mahoney, and Thomas W Beetham. Learn more on insiders at VRDN.

0.65% of Viridian Therapeutics stock is owned by insiders. Learn more on VRDN's insider holdings.

The following insiders have purchased VRDN shares in the last 24 months: Fairmount Funds Management Llc ($39,999,990.00), Scott Dunseth Myers ($261,805.00), Stephen F Mahoney ($499,262.00), and Thomas W Beetham ($117,050.00).

Insiders have purchased a total of 2,112,090 VRDN shares in the last 24 months for a total of $40,878,107.00 bought.

The following insiders have sold VRDN shares in the last 24 months: Barrett Katz ($2,750,668.70), Jonathan Violin ($1,840,000.00), and Lara Meisner ($1,926,701.10).

Insiders have sold a total of 194,112 Viridian Therapeutics shares in the last 24 months for a total of $6,517,369.80 sold.

Viridian Therapeutics Key Executives

  • Mr. Stephen F. Mahoney J.D. (Age 53)
    MBA, CEO, President & Director
    1 recent trades
  • Dr. Eric N. Olson Ph.D.
    Co-Founder & Chairman of Scientific Advisory Board
  • Dr. Michael R. Bristow M.D. (Age 79)
    Ph.D., Co-Founder & Member of the Scientific Advisory Board
  • Dr. Marvin H. Caruthers Ph.D. (Age 84)
    Co-Founder & Scientific Advisory Board Member
  • Mr. Vahe Bedian Ph.D.
    Co-Founder & Scientific Advisor
  • Mr. Seth Harmon
    Senior VP of Finance and Accounting, Principal Financial & Accounting Officer
  • Mr. Thomas W. Beetham J.D. (Age 54)
    MBA, Chief Operating Officer
    1 recent trades
  • Ms. Jennifer Tousignant J.D.
    Chief Legal Officer
  • Mr. John A. Jordan
    Vice President of Investor Relations & Corporate Communications
  • Mr. Anthony Casciano (Age 47)
    Chief Commercial Officer


This page (NASDAQ:VRDN) was last updated on 10/2/2024 by MarketBeat.com Staff
From Our Partners